Liquidia Techs., Inc. v. FDA

Start
Yutrepia® (treprostinil inhalation powder) – Case Name: Liquidia Techs., Inc. v. FDA, No. 24-2428 (D.D.C. Feb. 27, 2025) (Kelly, J.) Drug Product and Patent(s)-in-Suit: Yutrepia® (treprostinil inhalation powder) Nature of the Case and Issue(s) Presented: On January 24, 2020, Liquidia filed a 505(b)(2) NDA for its proposed drug Yutrepia®, a treprostinil inhalation powder….
By: Robins Kaplan LLP
Previous Story

The Bulk Data Access Rule: What Advertisers Need to Know

Next Story

The Expansion of Dog Owner Liability in New York